Literature DB >> 4049500

The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.

M Gumbleton, J E Brown, G Hawksworth, P H Whiting.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049500

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers.

Authors:  A Wahlländer; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs.

Authors:  A D'mello; R Venkataramanan; M Satake; S Todo; S Takaya; R J Ptachcinski; G J Burckart; T E Starzl
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1989-06

4.  Partial inhibition by cyclosporin A of the swelling of liver mitochondria in vivo and in vitro induced by sub-micromolar [Ca2+], but not by butyrate. Evidence for two distinct swelling mechanisms.

Authors:  A M Davidson; A P Halestrap
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

5.  Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.

Authors:  P H Whiting; N Barnard; A Neilsch; J G Simpson; M D Burke
Journal:  Br J Exp Pathol       Date:  1987-12

Review 6.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

Review 7.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.